Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 11;18(1):55.
doi: 10.1186/s13011-023-00563-w.

Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff

Li-Tzy Wu  1   2   3   4 , Paolo Mannelli  5 , William S John  6 , Alyssa Anderson  7 , Robert P Schwartz  8
Affiliations

Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff

Li-Tzy Wu et al. Subst Abuse Treat Prev Policy. .

Abstract

Background: The US federal regulations allow pharmacy administration and dispensing of methadone for opioid use disorder (PADMOUD) to increase the capability of opioid treatment programs (OTPs) in providing methadone maintenance treatment (MMT) for opioid use disorder (OUD) as part of a medication unit. However, there is a lack of research data from both pharmacy and OTP staff to inform the implementation of PADMOUD.

Methods: Staff of a pharmacy (n = 8) and an OTP (n = 9) that participated in the first completed US trial on PADMOUD through electronic prescribing for methadone (parent study) were recruited to participate in this qualitative interview study to explore implementation-related factors for PADMOUD. Each interview was recorded and transcribed verbatim. NVivo was used to help identify themes of qualitative interview data. The Promoting Action on Research Implementation in Health Services (PARIHS) framework was used to guide the coding and interpretation of data.

Results: Six pharmacy staff and eight OTP staff (n = 14) completed the interview. Results based on PARIHS domains were summarized, including evidence, context, and facilitation domains. Participants perceived benefits of PADMOUD for patients, pharmacies, OTPs, and payers. PADMOUD was considered to increase access for stable patients, provide additional patient service opportunities and revenues for pharmacies/pharmacists, enhance the capability of OTPs to treat more new patients, and reduce patients' cost when receiving medication at a pharmacy relative to an OTP. Both pharmacy and OTP staff were perceived to be supportive of the implementation of PADMOUD. Pharmacy staff/pharmacists were perceived to need proper training on addiction and methadone as well as a protocol of PADMOUD to conduct PADMOUD. Facilitators include having thought leaders to guide the operation, a certification program to ensure proper training of pharmacy staff/pharmacist, having updated pharmacy service software or technology to streamline the workflow of delivering PADMOUD and inventory management, and reimbursement for pharmacists.

Conclusion: This study presents the first findings on perspectives of PADMOUD from both staff of a community pharmacy and an OTP in the US. Finding on barriers and facilitators are useful data to guide the development of strategies to implement PADMOUD to help address the US opioid crisis.

Keywords: Community pharmacy; Methadone maintenance treatment; Methadone medication unit; Methadone prescribing; Opioid treatment program; Opioid use disorder.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2023. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
    1. Compton WM, Jones CM, Stein JB, Wargo EM. Promising roles for pharmacists in addressing the US opioid crisis. Res Social Administrative Pharm. 2019;15(8):910–6. doi: 10.1016/j.sapharm.2017.12.009. - DOI - PMC - PubMed
    1. Spencer MR, Miniño AM, Warner M. Drug Overdose Deaths in the United States, 2001–2021. NCHS Data Brief, no 457. Hyattsville, MD: National Center for Health Statistics 2022. 10.15620/cdc:122556.
    1. Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M. Has the treatment gap for opioid use disorder narrowed in the US?: a yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;110:103786. doi: 10.1016/j.drugpo.2022.103786. - DOI - PMC - PubMed
    1. Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117–27. doi: 10.1016/j.drugalcdep.2016.10.015. - DOI - PMC - PubMed

Publication types